J Vet Med Sci 66:197–199.
315 Itoh, H., T. Mukaiyama, T. Goto, et al. 2014. Non‐surgical treatment of canine oral malignant melanoma: A case study of the application of complementary alternative medicine. Oncol Lett 7:1829–1830.
316 Jackson, J., K.P. Richter, and D.P. Launer. 1999. Thoracoscopic partial pericardiectomy in 13 dogs. J Vet Intern Med 13:529–533.
317 Jacobs, T.M. and G.M. Rosen. 2000. Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog. J Am Anim Hosp Assoc 36:257–261.
318 Jeglum, K.A. 1996. Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231. Vet Clin North Am Small Anim Pract 26:73–85.
319 Jeglum, K.A., A. Whereat, and K. Young. 1983. Chemotherapy of canine thyroid carcinoma. Compend Contin Educ Pract Vet 5:96–98.
320 Jeglum, K.A., K.M. Young, K. Barnsley, et al. 1988. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma. Cancer 61:2042–2050.
321 Jourdier, T.M., C. Moste, M.C. Bonnet, et al. 2003. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10:2126–2132.
322 Kahn, S.A., C.M. Mullin, L.P. De Lorimier, et al. 2013. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study. Can Vet J 54:237–242.
323 Kane, R.C., W.D. McGuinnJr., R. Dagher, et al. 2008. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist 13:445–450.
324 Karayannopoulou, M., E. Kaldrymidou, T.C. Constantinidis, et al. 2001. Adjuvant post‐operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85–96.
325 Kaser‐Hotz, B., C.R. Rohrer, J.L. Fidel, et al. 2001. Radiotherapy in three suspect cases of feline thymoma. J Am Anim Hosp Assoc 37:483–488.
326 Kawabe, M., T. Mori, Y. Ito, et al. 2015. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006–2012). J Am Vet Med Assoc 247:1146–1153.
327 Keller, E.T., E.G. MacEwen, R.C. Rosenthal, et al. 1993. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 7:289–295.
328 Kent, E.M. 1993. Use of an immunostimulant as an aid in treatment and management of fibrosarcoma in three cats. Fel Pract 21:13.
329 Kent, M.S., A. Strom, and C.A. London. et al. 2004. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb‐sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 18:540–544.
330 Kerstetter, K.K., D.J. KrahwinkelJr., D.L. Millis, et al. 1997. Pericardiectomy in dogs: 22 cases (1978–1994). J Am Vet Med Assoc 211:736–740.
331 Keyerleber, M.A., T.L. Gieger, H.N. Erb, et al. 2012. Three‐dimensional conformal versus non‐graphic radiation treatment planning for apocrine gland adenocarcinoma of the anal sac in 18 dogs (2002–2007). Vet Comp Oncol 10:237–245.
332 Khanna, C., E.M. Lund, K.A. Redic, et al. 1998. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J Am Vet Med Assoc 213:985–990.
333 Kim, C., A. Matsuyama, A.J. Mutsaers, et al. 2017. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma. Can Vet J 58:1059–1064.
334 Kim, H., M. Nakaichi, K. Itamoto, et al. 2008. Malignant mixed tumor in the salivary gland of a cat. J Vet Sci 9:331–333.
335 King, G.K., K.M. Yates, P.M. Greenlace, et al. 1995. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J Am Anim Hosp Assoc 31:439–447.
336 Kirpensteijn, J., R.C. Straw, A.D. Pardo, et al. 1994. Partial and total scapulectomy in the dog. J Am Anim Hosp Assoc 30:313–319.
337 Kishimoto, T.E., H. Yoshimura, N. Saito, et al. 2015. Salivary gland epithelial‐myoepithelial carcinoma with high‐grade transformation in a dog. J Comp Pathol 153:111–115.
338 Kitchell, B.E., D.M. Brown, E.E. Luck, et al. 1994. Intralesional implant for treatment of primary oral malignant melanoma in dogs. J Am Vet Med Assoc 204:229–236.
339 Kiupel, M., J.D. Webster, K.L. Bailey, et al. 2011. Proposal of a 2‐tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 48:147–155.
340 Kiupel, M., J.D. Webster, R.A. Miller, et al. 2005. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. J Vet Med A Physiol Pathol Clin Med 52:280–286.
341 Klahn, S.L., B.E. Kitchell, and N.G. Dervisis. 2011. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. J Am Vet Med Assoc 239:90–96.
342 Klein, M.K., B.E. Powers, S.J. Withrow, et al. 1995. Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981–1989). J Am Vet Med Assoc 206:1007–1009.
343 Klueter, S., D. Krastel, E. Ludewig, et al. 2006. High‐dose‐rate brachytherapy for intranasal tumours in dogs: Results of a pilot study. Vet Comp Oncol 4:218–231.
344 Knapp, D.W., C.J. Henry, W.R. Widmer, et al. 2013. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 27:126–133.
345 Knapp, D.W., R.C. Richardson, T.C. Chan, et al. 1994. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8:273–278.
346 Knottenbelt, C.M., J.W. Simpson, S. Tasker, et al. 2000. Preliminary clinical observations on the use of piroxicam in the management of rectal tubulopapillary polyps. J Small Anim Pract 41:393–397.
347 Kobayashi, T., M.L. Hauck, R. Dodge, et al. 2002. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 43:473–479.
348 Kodre, V., M. Cemazar, J. Pecar, et al. 2009. Electrochemotherapy compared to surgery for treatment of canine mast cell tumors. in vivo 23:55–62.
349 Kolb, B.A., R.E. Buller, J.P. Connor, et al. 1992. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 79:988–992.
350 Konietschke, U., E. Teske, K. Jurina, et al. 2012. Palliative intralesional interleukin‐2 treatment in dogs with urinary bladder and urethral carcinomas. in vivo 26:931–935.
351 Kosovsky, J.K., D.T. Matthiesen, S.M. Marretta, et al. 1991. Results of partial mandibulectomy for the treatment of oral tumors in 142 dogs. Vet Surg 20:397–401.
352 Kosovsky, J.E., D.T. Matthiesen, and A.K. Patnaik. 1988. Small intestinal adenocarcinoma in cats: 32 cases (1978–1985). J Am Vet Med Assoc 192:233–235.
353 Kozicki, A.R., C. Robat, R. Chun, et al. 2015. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma. Vet Comp Oncol 13:229–236.
354 Kraje, A.C., E.A. Mears, K.A. Hahn, et al. 1999. Unusual metastatic behavior and clinicopathologic findings in eight cats with cutaneous or visceral hemangiosarcoma. J Am Vet Med Assoc 214:670–672.
355 Kramek, B.A., J.A. Spackman, and D.W. Hayden. 1985. Infiltrative lipoma in three dogs. J Am Vet Med Assoc 186:81–82.
356 Kramer, R.W., G.S. Price, and G.J. Spodnick. 1994. Hypothyroidism in a dog after surgery and radiation‐therapy for a functional thyroid adenocarcinoma. Vet Radiol Ultrasound 35:132–136.
357 Kry, K.L. and S.E. Boston. 2014. Additional local therapy with primary re‐excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs. Vet Surg 43:182–189.
358 Kryiazidou, A., P.J. Brown, and V.M. Lucke. 1989. Immunohistochemical